Use and Validation of an NMR Test for the Identity and O -acetyl content of the Salmonella typhi Vi Capsular Polysaccharide Vaccine

This publication has 13 references indexed in Scilit:

• Synthesis of α- and β-linked tyvelose epitopes of the Trichinella spiralis glycan: 2-acetamido-2-deoxy-3-O-(3,6-dideoxy-d-arabino-hexopyranosyl)-β-d-galactopyranosides
  Carbohydrate Research, 1996
• Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization
  Vaccine, 1996
• Multiple-Drug-Resistant Salmonella typhi
  Clinical Infectious Diseases, 1993
• Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.
  The Journal of Experimental Medicine, 1987
• PROTECTIVE ACTIVITY OF VI CAPSULAR POLYSACCHARIDE VACCINE AGAINST TYPHOID FEVER
  The Lancet, 1987
• Prevention of Typhoid Fever in Nepal with the VI Capsular Polysaccharide ofSalmonella Typhi
  New England Journal of Medicine, 1987
• Safety and Immunogenicity of Two Salmonella typhi Vi Capsular Polysaccharide Vaccines
  The Journal of Infectious Diseases, 1986
• Antigenic determinants of Salmonella serogroups A and D1.Synthesis of trisaccharide glycosides for use as artificial antigens
  Carbohydrate Research, 1982
• Identification of Salmonella typhi in faecal specimens by an antiserum-agar method
  Journal of Medical Microbiology, 1980
• Structural Studies on the O-Specific Side Chains of the Cell Wall Lipopolysaccharides from Salmonella typhi and S. enteritidis.
  Acta Chemica Scandinavica, 1969